10x Genomics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
TXG on Nasdaq
Location
Pleasanton, CA
Fiscal year end
31 December
Latest financial report
13 Feb 2026

Latest SEC snapshot (2025-12-31) highlights Return On Equity -5.8%, Return On Assets -4.4%, and Operating Margin -9.5%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

41.7/100

Caution Confidence high

Return On Equity

-5.8%

Metric score 0.0/100

Return On Assets

-4.4%

Metric score 0.0/100

Financial Health

Current Ratio
4.46x
Quick Ratio
4.09x
Debt to Equity
0.29x

Strengths

Debt-to-equity and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-5.8%

YoY: -77%

Industry median: -33% (n=32)

View history

Return On Assets

-4.4%

YoY: -77%

Industry median: -35% (n=32)

View history

Operating Margin

-9.5%

YoY: -70%

Industry median: -117% (n=29)

View history

Current Ratio

4.46x

YoY: -10%

Industry median: 2.39x (n=34)

View history

Quick Ratio

4.09x

YoY: +11%

Industry median: 1.68x (n=30)

View history

Debt-to-equity

0.29x

YoY: +0.38%

Industry median: 0.4x (n=33)

View history

Revenues YoY

5.2%

YoY:

Industry median: 8% (n=20)

View history

NetIncomeLoss YoY

76%

YoY:

Industry median: -0.5% (n=31)

View history

Profitability

Metric Latest value YoY change
Return On Equity -5.8% -77%
Return On Assets -4.4% -77%
Operating Margin -9.5% -70%

Financial Health

Metric Latest value YoY change
Current Ratio 4.46x -10%
Quick Ratio 4.09x +11%
Debt-to-equity 0.29x +0.38%

Growth

Metric Latest value YoY change
Revenues YoY 5.2%
NetIncomeLoss YoY 76%

Share Metrics

Metric Latest value YoY change
Common Stock, Shares, Outstanding 127,691,329 +4.4%
Common Stock, Value, Issued $2,000 0%
Weighted Average Number of Shares Outstanding, Basic 124,749,885 +3.6%
Weighted Average Number of Shares Outstanding, Diluted 124,749,885 +3.6%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $642,823,000 +5.2%
Cost of Revenue $198,942,000 +1.3%
Operating Income (Loss) $60,985,000 +69%
Nonoperating Income (Expense) $21,078,000 +25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $39,907,000 +78%
Income Tax Expense (Benefit) $3,637,000 -26%
Earnings Per Share, Basic -0.35 +77%
Earnings Per Share, Diluted -0.35 +77%
Accounts Receivable, after Allowance for Credit Loss, Current $47,013,000 -46%
Inventory, Net $56,341,000 -32%
Assets, Current $684,451,000 +17%
Property, Plant and Equipment, Net $226,711,000 -10%
Operating Lease, Right-of-Use Asset $60,450,000 +5.5%
Intangible Assets, Net (Excluding Goodwill) $62,329,000 +298%
Goodwill $4,511,000 0%
Other Assets, Noncurrent $2,913,000 -29%
Assets $1,041,365,000 +13%
Accounts Payable, Current $12,733,000 -1.4%
Employee-related Liabilities, Current $42,500,000 +26%
Contract with Customer, Liability, Current $23,902,000 +16%
Liabilities, Current $153,454,000 +30%
Contract with Customer, Liability, Noncurrent $10,501,000 -16%
Operating Lease, Liability, Noncurrent $73,376,000 +0.07%
Other Liabilities, Noncurrent $6,471,000 +29%
Liabilities $245,039,000 +18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $225,000
Retained Earnings (Accumulated Deficit) $1,510,591,000 -3%
Stockholders' Equity Attributable to Parent $796,326,000 +12%
Liabilities and Equity $1,041,365,000 +13%
Common Stock, Shares Authorized 1,100,000,000 0%
Common Stock, Shares, Issued 127,691,329 +4.4%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $473,966,000 +38%
Deferred Tax Assets, Valuation Allowance $490,154,000 +2.2%
Deferred Tax Assets, Gross $505,840,000 +1.9%
Operating Lease, Liability $84,361,000 +2.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $42,826,000 +77%
Lessee, Operating Lease, Liability, to be Paid $103,019,000 +1.8%
Property, Plant and Equipment, Gross $380,175,000 +1.2%
Operating Lease, Liability, Current $10,985,000 +18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $16,805,000 +9.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,630,000 +13%
Operating Lease, Weighted Average Discount Rate, Percent 0.059 +1.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,658,000 +0.45%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,394,000 +5.3%
Deferred Tax Assets, Operating Loss Carryforwards $202,704,000 +25%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 100,000,000 0%
Unrecognized Tax Benefits $55,490,000 +11%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,800,000 -6%
Preferred Stock, Shares Outstanding 0
Deferred Tax Assets, Net of Valuation Allowance $15,686,000 -6.2%
Share-based Payment Arrangement, Expense $108,804,000 -23%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%